It performs its antitumor functions by regulating oncogenic proteins such as EGFR, a steroid receptor coactivator 3 (SRC3), and androgen receptors in pancreatic, breast, and prostate cancers (106, 118, 119). Here, NCOA3 is linked to prostate cancer.